[HTML][HTML] Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
AA Khorana, J Palaia, L Rosenblatt… - … for immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Venous thromboembolism (VTE) is a significant cause of morbidity and
mortality in patients with lung cancer. Systemic therapies, such as chemotherapy (chemo) …
mortality in patients with lung cancer. Systemic therapies, such as chemotherapy (chemo) …
Utilization of pharmacy technicians to increase the accuracy of patient medication histories obtained in the emergency department
EC Rubin, R Pisupati, SF Nerenberg - Hospital Pharmacy, 2016 - journals.sagepub.com
Purpose The purpose of this study is to determine the accuracy of a pharmacy technician–
collected medication history pilot program in the emergency department. This was …
collected medication history pilot program in the emergency department. This was …
RISK OF venous thromboembolism in patients on first line therapy for advanced non-small cell lung cancer: a comparison of immune checkpoint inhibitors and …
Background: Venous thromboembolism (VTE) is a common cause of morbidity and mortality
in patients with lung cancer. Some anticancer therapies, including chemotherapy (chemo) …
in patients with lung cancer. Some anticancer therapies, including chemotherapy (chemo) …
Multifaceted approach to reduce use of meperidine in an acute care setting
R Pisupati - Hospital Pharmacy, 2007 - journals.sagepub.com
Purpose A system-wide approach to reduce inappropriate use of meperidine in a 651-bed
teaching hospital is described. Summary Baseline review indicated significant inappropriate …
teaching hospital is described. Summary Baseline review indicated significant inappropriate …
A practical approach for conversion to insulin pens in a health system
R Pisupati, S Kornblit, M Sobel… - Hospital Pharmacy, 2009 - journals.sagepub.com
Although patient-specific insulin pens offer advantages over insulin vials, institutions
converting to patient-specific pen use must plan for common practical problems and errors …
converting to patient-specific pen use must plan for common practical problems and errors …
440 Outcomes in patients with pre-existing autoimmune diseases who received immune checkpoint inhibitors: a real-world study
A Pavlick, J Palaia, R Pisupati, B Fu, K Wittstock… - 2022 - jitc.bmj.com
Background Autoimmune diseases (ADs) affect more than 24 million people in the United
States. Although patients with AD are usually excluded from ICI clinical trials, real world …
States. Although patients with AD are usually excluded from ICI clinical trials, real world …
439 Healthcare resource utilization in patients with pre-existing autoimmune diseases who received immune checkpoint inhibitors in the Marketscan database
J Palaia, A Pavlick, R Pisupati, B Fu, K Wittstock… - 2022 - jitc.bmj.com
Background Autoimmune diseases (ADs) affect more than 24 million people in the United
States. As patients with ADs are excluded from clinical trials of immune checkpoint inhibitors …
States. As patients with ADs are excluded from clinical trials of immune checkpoint inhibitors …
Standardized Drug Prescribing Forum: Glycemic Control Protocol for Adult Intensive Care
R Pisupati, J Wojcik - Hospital Pharmacy, 2006 - journals.sagepub.com
Patient safety is a complex issue that is constantly evolving. Communication via
standardized drug ordering is recognized as one of the key elements to providing a safer …
standardized drug ordering is recognized as one of the key elements to providing a safer …
[CITATION][C] Patient satisfaction in an urban outpatient anticoagulation clinic after transitioning from a point-of-care device to venipuncture
C Malabanan, M Villanueva… - JOURNAL OF …, 2013 - … VAN GODEWIJCKSTRAAT 30 …
[CITATION][C] Impact of pharmacist management versus physician management of inpatient warfarin
S Reveron, C Malabanan… - JOURNAL OF …, 2011 - … VAN GODEWIJCKSTRAAT 30 …